ID

21439

Description

Acute Promyelocytic Leukemia 2006 (APL); ODM derived from: https://clinicaltrials.gov/show/NCT00378365

Lien

https://clinicaltrials.gov/show/NCT00378365

Mots-clés

Versions (2)
  1. 21/04/2017 21/04/2017 -
  2. 21/04/2017 21/04/2017 -
Téléchargé le

21 avril 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Leukemia, Promyelocytic, Acute NCT00378365

Anglais

Eligibility Leukemia, Promyelocytic, Acute NCT00378365

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
diagnosis of apl based on morphological grounds, which will have to be confirmed by the presence of t(15;17) and/or pml-rara rearrangement with characterization of the bcr subtype (pml-rar characterization).
Description

Acute Promyelocytic Leukemia | t(15;17)(q22;q12) | t(15;17)(PML,RARA) | PML-RARa bcr1 fusion protein, human

Type de données

boolean

Alias
UMLS CUI [1]
C0023487
UMLS CUI [2]
C1515724
UMLS CUI [3]
C1979990
UMLS CUI [4]
C3493223
untreated patients.
Description

Patients Untreated

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0332155
no contraindication to intensive chemotherapy (especially well documented cardiac contraindication to idarubicin).
Description

Chemotherapy intense Medical contraindication Absent | Idarubicin Medical contraindication cardiac Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0522510
UMLS CUI [1,3]
C1301624
UMLS CUI [1,4]
C0332197
UMLS CUI [2,1]
C0020789
UMLS CUI [2,2]
C1301624
UMLS CUI [2,3]
C0018787
UMLS CUI [2,4]
C0332197
in female patients: absence of pregnancy and adequate contraceptive methods (due to teratogenetic effects of atra in early pregnancy).
Description

Gender Contraceptive methods | Pregnancy Absent | Tretinoin | Teratogenic effects Pregnancy Early

Type de données

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C0032961
UMLS CUI [2,2]
C0332197
UMLS CUI [3]
C0040845
UMLS CUI [4,1]
C0232910
UMLS CUI [4,2]
C0032961
UMLS CUI [4,3]
C1279919
absence of hypersensitivity to arsenic derivatives.
Description

Arsenic derivatives Hypersensitivity Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0003818
UMLS CUI [1,2]
C0243072
UMLS CUI [1,3]
C0020517
UMLS CUI [1,4]
C0332197
no qt interval prolongation or complete atria-ventricular block.
Description

Prolonged QT interval Absent | Complete atrioventricular block Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0151878
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0151517
UMLS CUI [2,2]
C0332197
written informed consent.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients already treated.
Description

Patients Treated

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1522326
patients with contraindication to intensive chemotherapy, especially well documented cardiac contraindication to idarubicin.
Description

Medical contraindication Chemotherapy intense | Medical contraindication cardiac Idarubicin

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0392920
UMLS CUI [1,3]
C0522510
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0018787
UMLS CUI [2,3]
C0020789
in female patients: pregnancy or absence of adequate contraceptive methods
Description

Pregnancy | Gender Contraceptive methods Absent

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C0332197
qt interval prolongation or complete atria-ventricular block.
Description

Prolonged QT interval | Complete atrioventricular block

Type de données

boolean

Alias
UMLS CUI [1]
C0151878
UMLS CUI [2]
C0151517
hypersensitivity to arsenic derivatives.
Description

Hypersensitivity Arsenic derivatives

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0003818
UMLS CUI [1,3]
C0243072
Retour au début de la page

Similar models

Eligibility Leukemia, Promyelocytic, Acute NCT00378365

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Acute Promyelocytic Leukemia | t(15;17)(q22;q12) | t(15;17)(PML,RARA) | PML-RARa bcr1 fusion protein, human
Item
diagnosis of apl based on morphological grounds, which will have to be confirmed by the presence of t(15;17) and/or pml-rara rearrangement with characterization of the bcr subtype (pml-rar characterization).
boolean
C0023487 (UMLS CUI [1])
C1515724 (UMLS CUI [2])
C1979990 (UMLS CUI [3])
C3493223 (UMLS CUI [4])
Patients Untreated
Item
untreated patients.
boolean
C0030705 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Chemotherapy intense Medical contraindication Absent | Idarubicin Medical contraindication cardiac Absent
Item
no contraindication to intensive chemotherapy (especially well documented cardiac contraindication to idarubicin).
boolean
C0392920 (UMLS CUI [1,1])
C0522510 (UMLS CUI [1,2])
C1301624 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
C0020789 (UMLS CUI [2,1])
C1301624 (UMLS CUI [2,2])
C0018787 (UMLS CUI [2,3])
C0332197 (UMLS CUI [2,4])
Gender Contraceptive methods | Pregnancy Absent | Tretinoin | Teratogenic effects Pregnancy Early
Item
in female patients: absence of pregnancy and adequate contraceptive methods (due to teratogenetic effects of atra in early pregnancy).
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0032961 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0040845 (UMLS CUI [3])
C0232910 (UMLS CUI [4,1])
C0032961 (UMLS CUI [4,2])
C1279919 (UMLS CUI [4,3])
Arsenic derivatives Hypersensitivity Absent
Item
absence of hypersensitivity to arsenic derivatives.
boolean
C0003818 (UMLS CUI [1,1])
C0243072 (UMLS CUI [1,2])
C0020517 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Prolonged QT interval Absent | Complete atrioventricular block Absent
Item
no qt interval prolongation or complete atria-ventricular block.
boolean
C0151878 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0151517 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Informed Consent
Item
written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Patients Treated
Item
patients already treated.
boolean
C0030705 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
Medical contraindication Chemotherapy intense | Medical contraindication cardiac Idarubicin
Item
patients with contraindication to intensive chemotherapy, especially well documented cardiac contraindication to idarubicin.
boolean
C1301624 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0522510 (UMLS CUI [1,3])
C1301624 (UMLS CUI [2,1])
C0018787 (UMLS CUI [2,2])
C0020789 (UMLS CUI [2,3])
Pregnancy | Gender Contraceptive methods Absent
Item
in female patients: pregnancy or absence of adequate contraceptive methods
boolean
C0032961 (UMLS CUI [1])
C0079399 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Prolonged QT interval | Complete atrioventricular block
Item
qt interval prolongation or complete atria-ventricular block.
boolean
C0151878 (UMLS CUI [1])
C0151517 (UMLS CUI [2])
Hypersensitivity Arsenic derivatives
Item
hypersensitivity to arsenic derivatives.
boolean
C0020517 (UMLS CUI [1,1])
C0003818 (UMLS CUI [1,2])
C0243072 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial